In a more recent study comparing sequential or concurrent CTRT (4 cycles of cisplatin etoposide and 45 Gy BD) on 213 patients with LS-SCLC, a survival improvement was observed in the concurrent arm, although the differences did not reach statistical significance ( 14 ).
1
—
—